Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
barrier decrease » barrier disease (Expand Search), marked decrease (Expand Search), barrier creates (Expand Search)
larger decrease » marked decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
barrier decrease » barrier disease (Expand Search), marked decrease (Expand Search), barrier creates (Expand Search)
larger decrease » marked decrease (Expand Search)
-
341
-
342
-
343
-
344
Variables for the bromeliad agent representing a single <i>T. utriculata</i> rosette.
Published 2025Subjects: -
345
-
346
-
347
-
348
-
349
-
350
-
351
-
352
-
353
-
354
-
355
Study Data.
Published 2025“…It has also been hypothesized that the bradycardia and rare instances of cardiac arrest occurring after the use of sugammadex may be due to a transient decrease in circulating corticosteroids, causing a temporary ‘mini Addisonian crisis.’ …”
-
356
Study outcomes.
Published 2025“…It has also been hypothesized that the bradycardia and rare instances of cardiac arrest occurring after the use of sugammadex may be due to a transient decrease in circulating corticosteroids, causing a temporary ‘mini Addisonian crisis.’ …”
-
357
Patient characteristics.
Published 2025“…It has also been hypothesized that the bradycardia and rare instances of cardiac arrest occurring after the use of sugammadex may be due to a transient decrease in circulating corticosteroids, causing a temporary ‘mini Addisonian crisis.’ …”
-
358
Sound stress exposure prolonged the period of decreased withdrawal threshold after complete Freund’s adjuvant (CFA) injection.
Published 2025“…(B) 50% withdrawal threshold in CFA-treated mice exposed to sound stress. They showed a significant decrease in 50% withdrawal threshold on day 7 after CFA injection, and CFA-treated mice exposed to sound stress showed a significant decrease in 50% withdrawal threshold during days 7–21 after CFA injection (CFA, on day 7, ****<i>P</i> < 0.001 vs day 0, on day 10, ***<i>P</i> < 0.001 vs day0; CFA + stress, day 7, 10, 14, and 21, ****<i>P</i> < 0.0001 vs day 0, Dunnett’s test). …”
-
359
-
360
Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque count.
Published 2025“…Each map represents a 3-dimensional view of statistically affected voxels (p < 0.05), where the red scale indicates a decrease in plaque count, and the cyan scale represents an increase. …”